A pilot study of chronic, low-dose epoetin-β following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure

Aims Low‐dose epoetin‐β improved neo‐angiogenesis and cardiac regeneration in experimental models of ischaemic cardiomyopathy without raising haemoglobin. No clinical study has tested this approach to date. Methods and results We performed a randomized, placebo‐controlled, double‐blind, single‐centr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of heart failure 2011-05, Vol.13 (5), p.560-568
Hauptverfasser:	Bergmann, Martin W., Haufe, Sven, von Knobelsdorff-Brenkenhoff, Florian, Mehling, Heidrun, Waßmuth, Ralf, Münch, Ines, Busjahn, Andreas, Schulz-Menger, Jeanette, Jordan, Jens, Luft, Friedrich C., Dietz, Rainer
Format:	Artikel
Sprache:	eng
Schlagworte:	Growth substances Heart failure Ischaemia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!